• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Insys Appoints Healthcare Finance Veteran as New CFO

July 18, 2017

 

 

Insys Therapeutics Inc. (NASDAQ:INSY), a developer of opioid pain therapeutics that also has some cannabinoid product candidates in its pipeline, today announced the appointment of Andrew G. Long as the company's new Chief Financial Officer, effective August 7th. 

 

Now Read: Insys Adds Four Pharma Industry Veterans To Leadership Team

 

Andrew G. Long has more than thirty years of experience in the finance departments of life sciences, biotechnology, pharmaceutical and industrial companies. Most recently, Mr. Long worked as a Senior Vice President of Global Finance at Patheon NV (NYSE:PTHN). While at Patheon, Long oversaw a number of initiatives leading up to Patheon’s IPO on the NYSE in 2016. 

 

Prior to his role at Patheon, Mr. Long worked at Thermo Fisher Scientific (NYSE:TMO), Cambrex Corporation (NYSE:CBM) and Abbott Laboratories (NYSE:ABT). 

 

If Abbott Laboratories sounds familiar to you, then it probably is, AbbVie Inc. (NYSE:ABBV) was spun out of Abbott Labs in 2013. AbbVie Inc. markets marketed a drug called Marinol. Marinol is a dronabinol capsule that is chemically identical to tetrahydrocannabinol, a.k.a. THC.

 

Now Read: Is AbbVie (NYSE:ABBV) a Marijuana Stock?

 

Saeed Motahari, President and Chief Executive Officer of Insys had this to say about the company's new hire:

 

“Andrew is a results-oriented, progressive leader with extensive global financial experience.  His breadth of experience and proven record of building organizations and developing talent will complement the strengths of our senior management team. We look forward to his leadership and guidance as we focus on growing our business and developing our pipeline candidates” 

 

He also thanked the company's previous CFO, Darryl Baker:

 

“I would like to thank Darryl Baker, who has served as our CFO since the Company’s IPO in 2013, for his commitment and many contributions to Insys.”

 

Now Read: 8 Marijuana Stocks Trading on the Nasdaq Exchange

 

For more information on Insys Therapeutics be sure to check out the company's profile in our global marijuana stock database. Remember, shares of Insys can be traded commission free using the Robinhood app

 

Subscribe to one or more of our free e-mail newsletters so you never miss an important cannabis stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via FacebookTwitterStockTwits, and Instagram

 

D/M/O

 

Disclaimer
 

Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.